amitriptyline has been researched along with Fabry Disease in 1 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
Fabry Disease: An X-linked inherited metabolic disease caused by a deficiency of lysosomal ALPHA-GALACTOSIDASE A. It is characterized by intralysosomal accumulation of globotriaosylceramide and other GLYCOSPHINGOLIPIDS in blood vessels throughout the body leading to multi-system complications including renal, cardiac, cerebrovascular, and skin disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| " A treatment plan was developed consisting of a low-dose morphine infusion with increasing dosage until pain was relieved." | 5.29 | Successful treatment of painful crises of Fabry disease with low dose morphine. ( Finley, GA; Gordon, KE; Ludman, MD, 1995) |
| " A treatment plan was developed consisting of a low-dose morphine infusion with increasing dosage until pain was relieved." | 1.29 | Successful treatment of painful crises of Fabry disease with low dose morphine. ( Finley, GA; Gordon, KE; Ludman, MD, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gordon, KE | 1 |
| Ludman, MD | 1 |
| Finley, GA | 1 |
1 other study available for amitriptyline and Fabry Disease
| Article | Year |
|---|---|
Successful treatment of painful crises of Fabry disease with low dose morphine.
Topics: Amitriptyline; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, | 1995 |